Early identification of hERG liability in drug discovery programs by automated patch clamp
Blockade of the cardiac ion channel coded by hERG can lead to cardiac arrhythmia, which has become a major concern in drug discovery and development. Automated electrophysiological patch clamp allows assessment of hERG channel effects early in drug development to aid medicinal chemistry programs and...
Saved in:
Main Authors: | Timm eDanker (Author), Clemens eMöller (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ensemble of structure and ligand-based classification models for hERG liability profiling
by: Serena Vittorio, et al.
Published: (2023) -
An Update on the Structure of hERG
by: Andrew Butler, et al.
Published: (2020) -
Stereoselective inhibition of the hERG1 potassium channel
by: Liliana eSintra Grilo, et al.
Published: (2010) -
Voltage-dependent gating of hERG potassium channels
by: Yen May eCheng, et al.
Published: (2012) -
Setting up a new gold standard: automated temperature-controlled hERG test on Patchliner®
by: Liudmila ePolonchuk
Published: (2012)